Skip to content

EBITDA at other companies

Tenet Healthcare logo
Tenet HealthcareTHC
-$7.3M+44.4%
United Therapeutics logo
United TherapeuticsUTHR
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
Arrowhead Research logo
Arrowhead ResearchARWR
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
BridgeBio Pharma logo
BridgeBio PharmaBBIO

Other financials

Income statement

See full
Revenue$132.9M+4,158%
Gross profit$1.6M+6.5%
Operating income$61.5M+274%
Net income$52.9M+238%
EPS (diluted)$0.52+216%

Balance sheet

See full
Cash & equivalents$222.8M+31.2%
Total debt$7.0M+1.5%
Total equity$108.6M+118%
Total assets$401.5M+76.6%

Cash flow

See full
Operating cash flow$53.0M+273%
CapEx$2.8M+758%
Free cash flow$50.2M+262%

Valuation

See full
Market cap$6.32B+164%
Enterprise value$6.1B+184%
P/S21.9×-147×

Profitability

See full
Gross margin58.1%-18.7pp
Operating margin-155%-68.1pp
Net margin-176.2%-76.4pp
FCF margin-150.7%-64.4pp

Returns & leverage

See full
Return on equity-181%+57.4pp
Debt / equity0.1×-0.1×
Current ratio2.2×-0.7×

Where this comes from

Calculated from Liquidia Corporation’s reported figures.

$61.5Mebit+
$497.0KDepreciation Depletion & Amortization
=$62M

The official record: Liquidia Corporation’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Liquidia Corporation's ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Liquidia Corporation's EBITDA?
Liquidia Corporation (LQDA) reported EBITDA of $62M in Q1 2026.
How has Liquidia Corporation's EBITDA changed year-over-year?
Liquidia Corporation's EBITDA increased by 277.3% year-over-year, from -$34.97M to $62M.
What is the long-term trend for Liquidia Corporation's EBITDA?
Over 3 years (2021 to 2024), Liquidia Corporation's EBITDA has grown at a 61.7% compound annual growth rate (CAGR), from -$28.19M to -$119.1M.
What does EBITDA mean?
Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.